We came across a bullish thesis on Cencora, Inc. (COR) on Substack by Hidden Market Gems. In this article, we will summarize ...

Since April 2020, the S&P 500 has delivered a total return of 101%. But one standout stock has more than doubled the market - over the past five years, Cencora has surged 231% to $285.36 per share.

AmerisourceBergen’s move into the digital health area is part of a revamp of the business, which will be renamed Cencora later this year to reflect a change in business strategy, with ...

Formerly known as AmerisourceBergen until its 2023 rebranding, Cencora (NYSE:COR) is a global pharmaceutical distribution company that connects manufacturers with healthcare providers while ...

Pharma distributor AmerisourceBergen is working on a platform to make access to digital therapeutics (DTx) easier in the US by providing a unified system for ordering, dispensing and fulfilment.

Morgan Stanley analyst Erin Wright raised the firm’s price target on Cencora (COR) to $288 from $263 and keeps an Equal Weight rating on the shares. While policy will be “front and center ...

Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 8.3% over the past month. The stock hit a new 52-week high of $271.86 in the previous session.